Skip to main content
. 2022 Aug 25;46(1):56–87. doi: 10.1007/s10753-022-01730-0

Table 1.

Details of NLRP3 Inhibitor and Their Mechanism of Action

NLRP3 inhibitor Class of drug Mechanism of action
Glyburide Sulfonylureas Suppressed KATP channels and inhibition of ASC agglomeration
MCC950 Hydrolysis of ATP
Metformin Biguanide Activation of AMPK
Liraglutide GLP‐1 analogs Inhibition of NLRP3 inflammasome
Dapagliflozin SGLT‐2 inhibitors Activation of AMPK
Empagliflozin
Ticagrelor
CY‐09 Glitazones Inhibition of NLRP3 ATPase activity
Arsenic trioxide(As2O3) Arsenic compounds Inhibition of NLRP3 activation and release of IL‐1β
Edaravone Substituted 2‐pyrazolin‐5‐ones Inhibition of NLRP3 activation and release of IL‐1β. Reduced caspase-1 and NF-kB expression and ROS scavenging
Atorvastatin Statins Inhibition of NLRP3 activation and release of IL‐1β. Reduced caspase-1 and NF-kB expression and ROS scavenging
Allopurinol Xanthine oxidase inhibitor Scavenging of ROS and inhibition of uric acid production
BAY11‐7082 Vinyl sulfones Inhibition of ATPase
MNS Beta‐Nitrostyrenes Alteration of cysteine residue and inhibition of ATPase
INF39 Acrylate derivatives Inhibition of ATPase
EMD638683 Acylhydrazone Reduced NLRP3 and IL‐1β expression
FC11A‐2 Benzimidazoles Inhibition of autocleavage of pro‐caspase‐1 and IL‐1β expression
Dapansutrile (OLT1177) Sulfonyl nitriles Inhibitor of NACHT and ATPase
BOT‐4‐one Benzoxathiole derivatives Inhibitor of NACHT and ATPase
Tranilast Tryptophan derivative Binds with the NACHT and inhibits the interaction of NLRP3–NLRP3 and NLRP3-ASC
BHB Natural products Inhibition of outward movement of K+ and reduced agglomeration
Parthenolide Inhibitor of NACHT ATPase and caspase-1 inhibitor
Oridonin Binds irreversibly with Cys27 residue of NLRP3 9 and inhibits the interaction of NLRP3–NEK7